Drug intelligence / Profile preview

A-205804

Development stage
Preclinical
Lead developer
Pfizer
Modality
Small Molecules
Administration
Oral
01

Overview

A-205804 is a potent and selective small molecule inhibitor of E-selectin and intercellular adhesion molecule-1 (ICAM-1) expression.[1][3] The compound functions as an inhibitor of cell adhesion molecules that mediate endothelial-leukocyte interactions essential in inflammatory responses.[1] Mechanistically, A-205804 translocates to the nucleus and binds non-covalently to large molecular targets (>650 kDa).[1] It is orally bioavailable and serves as a research tool for studying inflammatory processes and adhesion-associated diseases, including potential applications in cancer research and neuropathic pain models.[2][4]

Other names
4-[(4-methylphenyl)thio]thieno[2,3-c]pyridine-2-carboxamide4-(4-methylphenyl)sulfanylthieno[2,3-c]pyridine-2-carboxamide
02

Targets

SELE (E-selectin)ICAM1 (Intercellular Adhesion Molecule 1)

Beyond the preview

Go deeper on A-205804.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on A-205804.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call